LAM-003 not checked

IRulya Therapeutics Inc.

FollowEvery change as it happens, and a Monday email
Stage
No active trials
 
Next date
None yet
 
Trials
0 active
1 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
Oncology, Acute Myeloid Leukemia
Main trialPhase 1
“A Phase 1 Dose-Escalation Study of LAM-003 in Patients with Acute Myeloid Leukemia”In the company’s words, NCT03426605 on ClinicalTrials.gov

Other drugs for Oncology

All 2439 drugs for Oncology

Coming up0

No dates coming up.

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials1

TrialPhaseCompletesWhat it tests
Phase 1Completed 20 Feb 2020 A Study of LAM-003 in Patients With Acute Myeloid Leukemia
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow LAM-003

Following is part of Solo: you see every change to LAM-003 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in